GlassScriptPhysician profile
William S Polachek
NPI 1457845695
$9,352.78
in general payments reported to CMS, 2019-2025
17 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $133 · 2021: $257 · 2022: $819 · 2023: $2,519 · 2024: $4,625 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,699 · Food and Beverage: $2,952 · Education: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,698.79 |
| Food and Beverage | $2,951.93 |
| Education | $1,493.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,756.30 | 2020-2025 | Infinity Adaptis, Prophecy, Prostep Mica |
| Paragon 28, INC. | $1,692.70 | 2023 | Portfolio, Apex 3d |
| Vilex LLC | $1,614.51 | 2024 | |
| Arthrex, INC. | $1,021.85 | 2024 | |
| Pylant Medical | $284.01 | 2023-2025 | |
| Medshape, INC. | $176.86 | 2024-2025 | Dynanail, Dynanail Helix, Washer, 15 Mm |
| Smith+Nephew, INC. | $167.25 | 2025 | Spatial Frame, Acufex Meniscal Root Repair, Novostitch |
| Orthopediatrics Corp. | $144.05 | 2022-2023 | |
| Abbott Laboratories | $137.60 | 2025 | Proclaim |
| Linvatec Corporation | $88.29 | 2025 | Biobrace 23mm |
| Innovation Technologies INC | $50.10 | 2025 | Irrisept |
| Orthofix Medical, INC. | $46.79 | 2023 | Truelok |
| Pacira Pharmaceuticals Incorporated | $46.10 | 2025 | Exparel |
| Becton, Dickinson and Company | $40.70 | 2025 | |
| Bioventus LLC | $39.87 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $23.26 | 2025 | Euflexxa |
| Pacira Therapeutics, INC. | $22.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Polachek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.